Pub Date : 2024-10-07DOI: 10.1088/1752-7163/ad7eef
Tao Chen, Mengqi Jin, Liqing Chen, Xi Xuan Cai, Yilin Huang, Keqing Shen, Yi Li, Xing Chen, Liying Chen
Depression is a pervasive and often undetected mental health condition, which poses significant challenges for early diagnosis due to its silent and subtle nature. To evaluate exhaled volatile organic compounds (VOCs) as non-invasive biomarkers for the detection of depression using a virtual surface acoustic wave sensors array (VSAW-SA). A total of 245 participants were recruited from the Hangzhou Community Health Service Center, including 38 individuals diagnosed with depression and 207 control subjects. Breath samples were collected from all participants and subjected to analysis using VSAW-SA. Univariate and multivariate analyses were employed to assess the relationship between VOCs and depression. The findings revealed that the responses of virtual sensor ID 14, 44, 59, and 176, which corresponded respectively to ethanol, trichloroethylene or isoleucine, octanoic acid or lysine, and an unidentified compound, were sensitive to depression. Taking into account potential confounders, these sensor responses were utilized to calculate a depression detection indicator. It has a sensitivity of 81.6% and a specificity of 81.6%, with an area under the curve of 0.870 (95% CI = 0.816-0.923). Conclusions: exhaled VOCs as non-invasive biomarkers of depression could be detected by a VSAW-SA. Large-scale cohort studies should be conducted to confirm the potential ability of the VSAW-SA to diagnose depression.
{"title":"Rapid detection of depression by volatile organic compounds from exhalation.","authors":"Tao Chen, Mengqi Jin, Liqing Chen, Xi Xuan Cai, Yilin Huang, Keqing Shen, Yi Li, Xing Chen, Liying Chen","doi":"10.1088/1752-7163/ad7eef","DOIUrl":"10.1088/1752-7163/ad7eef","url":null,"abstract":"<p><p>Depression is a pervasive and often undetected mental health condition, which poses significant challenges for early diagnosis due to its silent and subtle nature. To evaluate exhaled volatile organic compounds (VOCs) as non-invasive biomarkers for the detection of depression using a virtual surface acoustic wave sensors array (VSAW-SA). A total of 245 participants were recruited from the Hangzhou Community Health Service Center, including 38 individuals diagnosed with depression and 207 control subjects. Breath samples were collected from all participants and subjected to analysis using VSAW-SA. Univariate and multivariate analyses were employed to assess the relationship between VOCs and depression. The findings revealed that the responses of virtual sensor ID 14, 44, 59, and 176, which corresponded respectively to ethanol, trichloroethylene or isoleucine, octanoic acid or lysine, and an unidentified compound, were sensitive to depression. Taking into account potential confounders, these sensor responses were utilized to calculate a depression detection indicator. It has a sensitivity of 81.6% and a specificity of 81.6%, with an area under the curve of 0.870 (95% CI = 0.816-0.923). Conclusions: exhaled VOCs as non-invasive biomarkers of depression could be detected by a VSAW-SA. Large-scale cohort studies should be conducted to confirm the potential ability of the VSAW-SA to diagnose depression.</p>","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-04DOI: 10.1088/1752-7163/ad836d
Danial Abu Shkara, Yoav Keynan, Shay Brikman, Guy Dori
Patients with respiratory infections (e.g., COVID-19, antimicrobial resistant bacteria) discharge pathogens to the environment, exposing healthcare workers and inpatients to deleterious complications. This study tested the performance of SPEAR-P1 (synchronized personal exhaled air removal system - prototype 1), which actively detects expiration and removes exhaled air using an open, non-sealing lightweight facemask connected to a deep vacuum generating unit (DVGU). Fourteen healthy examinees practiced breathing through facemasks at 30, 25 and 20 breaths per minute; oxygen and nebulized saline were added at later steps. To test the efficacy of removing exhaled air, CO2 was used as a proxy and its level was measured from the outer surface of the open facemask. Compared to the baseline recording, SPEAR-P1 reduced CO2 escaping from the facemask by 66% on average for all study steps and respiratory rates (p<0.001), reaching 85.55% on average at 20 breaths per minute (p<0.001). This study shows that removing exhaled air from examinees using an open, non-sealing lightweight facemask is feasible. Future development of this system will enhance its efficacy and provide a method to remove a patient's contaminating aerosol without the need to "seal" the patient, especially in settings where isolation rooms are not readily available.
{"title":"A Novel System for Removing Examinee's Exhaled Air Using an Open, Lightweight Non-Sealing Facemask - a Proof-of-Concept Study.","authors":"Danial Abu Shkara, Yoav Keynan, Shay Brikman, Guy Dori","doi":"10.1088/1752-7163/ad836d","DOIUrl":"10.1088/1752-7163/ad836d","url":null,"abstract":"<p><p>Patients with respiratory infections (e.g., COVID-19, antimicrobial resistant bacteria) discharge pathogens to the environment, exposing healthcare workers and inpatients to deleterious complications. This study tested the performance of SPEAR-P1 (synchronized personal exhaled air removal system - prototype 1), which actively detects expiration and removes exhaled air using an open, non-sealing lightweight facemask connected to a deep vacuum generating unit (DVGU). Fourteen healthy examinees practiced breathing through facemasks at 30, 25 and 20 breaths per minute; oxygen and nebulized saline were added at later steps. To test the efficacy of removing exhaled air, CO2 was used as a proxy and its level was measured from the outer surface of the open facemask. Compared to the baseline recording, SPEAR-P1 reduced CO2 escaping from the facemask by 66% on average for all study steps and respiratory rates (p<0.001), reaching 85.55% on average at 20 breaths per minute (p<0.001). This study shows that removing exhaled air from examinees using an open, non-sealing lightweight facemask is feasible. Future development of this system will enhance its efficacy and provide a method to remove a patient's contaminating aerosol without the need to \"seal\" the patient, especially in settings where isolation rooms are not readily available.</p>","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Occupational asthma (OA) is divided into allergic asthma (AA) and irritant-induced asthma (IIA). IIA can be divided further into three different phenotypic subtypes. Volatile organic compounds (VOCs) in exhaled breath can reflect metabolic changes in the body, and a wide range of them have been associated with various diseases in the last two decades. This is the first known study to explore breath VOCs in subjects with OA, aimed to identify potential biomarkers to distinguish OA from healthy controls, as well as between different OA subgroups. In a cross-sectional investigation, exhaled breath from 40 patients with OA and 45 respiratory healthy healthcare workers were collected with ReCIVA® Breath Sampler. Samples were analyzed through an untargeted approach using thermal desorption-gas chromatography mass spectrometry (TD-GC-MS), and VOCs were identified according to tier classification. The data underwent analysis using both non-parametric and parametric statistical methods. 536 VOCs were identified. Significance (p<0.05) was observed in several emitted VOCs. Among these, compounds such as 1-hexadecanol, 2,3-butanediol, xylene, phenol, acetone, 3-methylhexane, methylcyclohexane, and isoprene have biological implications or are associated with exposures linked to OA. These VOCs may reflect metabolic changes in the body and the microbiome, as well as external exposures due to occupation.
In particular, 1-hexadecanol, 2,3-butanediol, xylene and phenol are associated with reduced nicotinamide adenine dinucleotide (NADH) and production of reactive oxygen species (ROS), mechanisms that can be linked to asthmatic diseases and therefore suggests its potential as biomarkers. This study demonstrates that VOCs detected in exhaled breath could serve as indicators of occupational exposure and enhance diagnostic accuracy for asthma.
.
职业性哮喘(OA)分为过敏性哮喘(AA)和刺激性哮喘(IIA)。IIA 又可分为三种不同的表型亚型。呼出气体中的挥发性有机化合物(VOCs)可以反映人体的新陈代谢变化,在过去二十年中,有多种挥发性有机化合物与各种疾病相关。这是第一项对患有 OA 的受试者进行呼出气体挥发性有机化合物检测的已知研究,旨在确定潜在的生物标志物,以区分 OA 和健康对照组,以及不同 OA 亚组之间的差异。在一项横断面调查中,研究人员使用 ReCIVA® 呼吸采样器收集了 40 名 OA 患者和 45 名呼吸系统健康的医护人员的呼出气体。采用热脱附-气相色谱质谱法(TD-GC-MS)对样本进行了非靶向分析,并根据等级分类确定了挥发性有机化合物。使用非参数和参数统计方法对数据进行了分析。共鉴定出 536 种挥发性有机化合物。在几种排放的挥发性有机化合物中观察到了显著性(p<0.05)。其中,1-十六烷醇、2,3-丁二醇、二甲苯、苯酚、丙酮、3-甲基己烷、甲基环己烷和异戊二烯等化合物对生物有影响,或与 OA 暴露有关。特别是,1-十六醇、2,3-丁二醇、二甲苯和苯酚与烟酰胺腺嘌呤二核苷酸(NADH)的减少和活性氧(ROS)的产生有关,这些机制可能与哮喘疾病有关,因此表明它们有可能成为生物标记物。这项研究表明,呼出气体中检测到的挥发性有机化合物可以作为职业暴露的指标,并提高哮喘诊断的准确性。
{"title":"Exploring exhaled breath volatile organic compounds in occupational asthma: A pilot cross-sectional study.","authors":"Hilde Heiro,Tonje Trulssen Hildre,Amy Craster,Liam Grimmett,Matteo Tardelli,Bato Hammarström","doi":"10.1088/1752-7163/ad7b6a","DOIUrl":"https://doi.org/10.1088/1752-7163/ad7b6a","url":null,"abstract":"Occupational asthma (OA) is divided into allergic asthma (AA) and irritant-induced asthma (IIA). IIA can be divided further into three different phenotypic subtypes. Volatile organic compounds (VOCs) in exhaled breath can reflect metabolic changes in the body, and a wide range of them have been associated with various diseases in the last two decades. This is the first known study to explore breath VOCs in subjects with OA, aimed to identify potential biomarkers to distinguish OA from healthy controls, as well as between different OA subgroups. In a cross-sectional investigation, exhaled breath from 40 patients with OA and 45 respiratory healthy healthcare workers were collected with ReCIVA® Breath Sampler. Samples were analyzed through an untargeted approach using thermal desorption-gas chromatography mass spectrometry (TD-GC-MS), and VOCs were identified according to tier classification. The data underwent analysis using both non-parametric and parametric statistical methods. 536 VOCs were identified. Significance (p<0.05) was observed in several emitted VOCs. Among these, compounds such as 1-hexadecanol, 2,3-butanediol, xylene, phenol, acetone, 3-methylhexane, methylcyclohexane, and isoprene have biological implications or are associated with exposures linked to OA. These VOCs may reflect metabolic changes in the body and the microbiome, as well as external exposures due to occupation.
In particular, 1-hexadecanol, 2,3-butanediol, xylene and phenol are associated with reduced nicotinamide adenine dinucleotide (NADH) and production of reactive oxygen species (ROS), mechanisms that can be linked to asthmatic diseases and therefore suggests its potential as biomarkers. This study demonstrates that VOCs detected in exhaled breath could serve as indicators of occupational exposure and enhance diagnostic accuracy for asthma.
.","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":"30 1","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142261936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Exhaled breath condensate (EBC) is used as a promising noninvasive diagnostic tool in the field of respiratory medicine. EBC is achieved by cooling exhaled air, which contains aerosolized particles and volatile compounds present in the breath. This method provides useful information on the biochemical and inflammatory state of the airways. In respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, EBC analysis can reveal elevated levels of biomarkers such as hydrogen peroxide, nitric oxide and various cytokines, which correlate with oxidative stress and inflammation.
Furthermore, the presence of certain volatile organic compounds (VOCs) in EBC has been linked to specific respiratory conditions, potentially serving as disease-specific fingerprints. The noninvasive nature of EBC sampling makes it particularly useful for repeated measures and for use in vulnerable populations, including children and the elderly. Despite its potential, the standardization of collection methods, analytical techniques and interpretation of results currently limits its use in clinical practice.
Nonetheless, EBC holds significant promise for improving the diagnosis, monitoring and therapy of respiratory diseases.
In this tutorial we will present the latest advances in EBC research in airway diseases and future prospects for clinical applications of EBC analysis, including the application of the Omic sciences for its analysis.
.
{"title":"Exhaled breath condensate (EBC) in respiratory diseases: Recent advances, and future perspectives in the age of Omic sciences.","authors":"Mauro Maniscalco,Claudio Candia,Salvatore Fuschillo,Pasquale Ambrosino,Debora Paris,Andrea Motta","doi":"10.1088/1752-7163/ad7a9a","DOIUrl":"https://doi.org/10.1088/1752-7163/ad7a9a","url":null,"abstract":"Exhaled breath condensate (EBC) is used as a promising noninvasive diagnostic tool in the field of respiratory medicine. EBC is achieved by cooling exhaled air, which contains aerosolized particles and volatile compounds present in the breath. This method provides useful information on the biochemical and inflammatory state of the airways. In respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, EBC analysis can reveal elevated levels of biomarkers such as hydrogen peroxide, nitric oxide and various cytokines, which correlate with oxidative stress and inflammation. 
Furthermore, the presence of certain volatile organic compounds (VOCs) in EBC has been linked to specific respiratory conditions, potentially serving as disease-specific fingerprints. The noninvasive nature of EBC sampling makes it particularly useful for repeated measures and for use in vulnerable populations, including children and the elderly. Despite its potential, the standardization of collection methods, analytical techniques and interpretation of results currently limits its use in clinical practice. 
Nonetheless, EBC holds significant promise for improving the diagnosis, monitoring and therapy of respiratory diseases.
In this tutorial we will present the latest advances in EBC research in airway diseases and future prospects for clinical applications of EBC analysis, including the application of the Omic sciences for its analysis.
.","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":"30 1","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142262032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-12DOI: 10.1088/1752-7163/ad7a20
Michael Phillips,Therese Bevers,Linda Larsen,Nadine Pappas,Sonali Pathak
Previous studies have reported volatile organic compounds (VOCs) in the breath as biomarkers of breast cancer. These biomarkers may be derived from cancer-associated fibroblasts, in which oxidative stress degrades polyunsaturated fatty acids to volatile alkanes and methylated alkane derivatives that are excreted in the breath. We evaluated a rapid point-of-care test for breath VOC biomarkers as predictors of breast cancer and abnormal mammograms.
Methods: We studied 593 women aged ≥ 18 yr referred to three sites for mammography for a symptomatic breast-related concern (e.g. breast mass, nipple discharge). A rapid point-of-care breath testing system collected and concentrated alveolar breath VOCs on a sorbent trap and analyzed them with gas chromatography and surface acoustic wave detection in < 6 min. Breath VOC chromatograms were randomly assigned to a training set or to a validation set. Monte Carlo analysis identified significant breath VOC biomarkers of breast cancer and abnormal mammograms in the training set, and these biomarkers were incorporated into a multivariate algorithm to predict disease in the validation set.
Results: Prediction of breast cancer: 50 women had biopsy-proven breast cancer (invasive cancer 41, ductal non-invasive cancer 9)
Unsplit data set: Breath VOCs identified breast cancer with 83% accuracy (area under curve of receiver operating characteristic), 82% sensitivity and 77.1% specificity.
Split data sets: Training set breath VOCs identified breast cancer with 80.3% accuracy, 84% sensitivity and 74.3% specificity. Corresponding values in the validation set were 68%% accuracy, 72.4% sensitivity and 61.5% specificity.
Prediction of BIRADS 4 and 5 mammograms (versus BIRADS 1, 2 and 3):
Unsplit data set: Breath VOCs identified abnormal mammograms with 76.2% accuracy.
Split data sets: Breath VOCs identified abnormal mammograms with 74.2% accuracy, 73.3% sensitivity and 60% specificity. Corresponding values in the validation set were 60.5% accuracy, 64.2% sensitivity and 51% specificity.
Conclusions: A rapid point-of-care test for breath VOC biomarkers predicted risk of breast cancer and abnormal mammograms in women with breast-related symptoms.
.
以往的研究报告称,呼气中的挥发性有机化合物(VOC)是乳腺癌的生物标志物。这些生物标志物可能来自与癌症相关的成纤维细胞,在成纤维细胞中,氧化应激将多不饱和脂肪酸降解为挥发性烷烃和甲基化烷烃衍生物,并随呼吸排出体外。我们评估了一种快速的呼气挥发性有机化合物生物标志物床旁检测方法,该方法可预测乳腺癌和乳房 X 光检查异常:我们对 593 名年龄≥ 18 岁的女性进行了研究,她们因乳房相关症状(如乳房肿块、乳头溢液)而被转诊到三个地点进行乳房 X 光检查。快速护理点呼气检测系统在吸附剂捕集器上收集并浓缩肺泡呼气中的挥发性有机化合物,并在 < 6 分钟内用气相色谱法和表面声波检测法对其进行分析。呼气挥发性有机化合物色谱图被随机分配到训练集或验证集。蒙特卡洛分析确定了训练集中乳腺癌和乳房 X 线照片异常的重要呼出气体挥发性有机化合物生物标志物,并将这些生物标志物纳入多元算法,以预测验证集中的疾病:乳腺癌预测:50 名妇女经活检证实患有乳腺癌(浸润性癌症 41 例,导管非浸润性癌症 9 例)
未拆分数据集:呼吸挥发性有机化合物识别乳腺癌的准确率为 83%(接收者操作特征曲线下面积),灵敏度为 82%,特异性为 77.1%:训练集呼气 VOCs 鉴定乳腺癌的准确率为 80.3%,灵敏度为 84%,特异性为 74.3%。验证集的相应准确率为 68%%,灵敏度为 72.4%,特异性为 61.5%。
预测 BIRADS 4 和 5 乳房 X 线照片(相对于 BIRADS 1、2 和 3):
未拆分数据集:呼吸 VOC 识别异常乳房 X 光照片的准确率为 76.2%:呼吸 VOCs 识别异常乳房 X 光照片的准确率为 74.2%,灵敏度为 73.3%,特异性为 60%。验证集中的相应值为:准确率 60.5%、灵敏度 64.2%、特异性 51%:呼出挥发性有机化合物生物标记物的快速床旁检测可预测有乳腺相关症状的妇女罹患乳腺癌的风险和乳房 X 光检查异常的情况。
{"title":"Rapid point-of-care breath test predicts breast cancer and abnormal mammograms in symptomatic women.","authors":"Michael Phillips,Therese Bevers,Linda Larsen,Nadine Pappas,Sonali Pathak","doi":"10.1088/1752-7163/ad7a20","DOIUrl":"https://doi.org/10.1088/1752-7163/ad7a20","url":null,"abstract":"Previous studies have reported volatile organic compounds (VOCs) in the breath as biomarkers of breast cancer. These biomarkers may be derived from cancer-associated fibroblasts, in which oxidative stress degrades polyunsaturated fatty acids to volatile alkanes and methylated alkane derivatives that are excreted in the breath. We evaluated a rapid point-of-care test for breath VOC biomarkers as predictors of breast cancer and abnormal mammograms.
Methods: We studied 593 women aged ≥ 18 yr referred to three sites for mammography for a symptomatic breast-related concern (e.g. breast mass, nipple discharge). A rapid point-of-care breath testing system collected and concentrated alveolar breath VOCs on a sorbent trap and analyzed them with gas chromatography and surface acoustic wave detection in < 6 min. Breath VOC chromatograms were randomly assigned to a training set or to a validation set. Monte Carlo analysis identified significant breath VOC biomarkers of breast cancer and abnormal mammograms in the training set, and these biomarkers were incorporated into a multivariate algorithm to predict disease in the validation set. 
Results: Prediction of breast cancer: 50 women had biopsy-proven breast cancer (invasive cancer 41, ductal non-invasive cancer 9)
Unsplit data set: Breath VOCs identified breast cancer with 83% accuracy (area under curve of receiver operating characteristic), 82% sensitivity and 77.1% specificity.
Split data sets: Training set breath VOCs identified breast cancer with 80.3% accuracy, 84% sensitivity and 74.3% specificity. Corresponding values in the validation set were 68%% accuracy, 72.4% sensitivity and 61.5% specificity.
Prediction of BIRADS 4 and 5 mammograms (versus BIRADS 1, 2 and 3): 
Unsplit data set: Breath VOCs identified abnormal mammograms with 76.2% accuracy.
Split data sets: Breath VOCs identified abnormal mammograms with 74.2% accuracy, 73.3% sensitivity and 60% specificity. Corresponding values in the validation set were 60.5% accuracy, 64.2% sensitivity and 51% specificity.
Conclusions: A rapid point-of-care test for breath VOC biomarkers predicted risk of breast cancer and abnormal mammograms in women with breast-related symptoms.

.","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":"23 1","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142261935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-11DOI: 10.1088/1752-7163/ad7166
Liam D Little, Sarah E Barnett, Theo Issitt, Sam Bonsall, Vikki A Carolan, Elizabeth Allen, Laura M Cole, Neil A Cross, Judy M Coulson, Sarah L Haywood-Small
Malignant pleural mesothelioma (MPM) is an aggressive cancer associated with asbestos exposure. MPM is often diagnosed late, at a point where limited treatment options are available, but early intervention could improve the chances of successful treatment for MPM patients. Biomarkers to detect MPM in at-risk individuals are needed to implement early diagnosis technologies. Volatile organic compounds (VOCs) have previously shown diagnostic potential as biomarkers when analysed in MPM patient breath. In this study, chorioallantoic membrane (CAM) xenografts of MPM cell lines were used as models of MPM tumour development for VOC biomarker discovery with the aim of generating targets for investigation in breath, biopsies or other complex matrices. VOC headspace analysis of biphasic or epithelioid MPM CAM xenografts was performed using solid-phase microextraction and gas chromatography-mass spectrometry. We successfully demonstrated the capture, analysis and separation of VOC signatures from CAM xenografts and controls. A panel of VOCs was identified that showed discrimination between MPM xenografts generated from biphasic and epithelioid cells and CAM controls. This is the first application of the CAM xenograft model for the discovery of VOC biomarkers associated with MPM histological subtypes. These findings support the potential utility of non-invasive VOC profiling from breath or headspace analysis of tissues for detection and monitoring of MPM.
{"title":"Volatile organic compound analysis of malignant pleural mesothelioma chorioallantoic membrane xenografts.","authors":"Liam D Little, Sarah E Barnett, Theo Issitt, Sam Bonsall, Vikki A Carolan, Elizabeth Allen, Laura M Cole, Neil A Cross, Judy M Coulson, Sarah L Haywood-Small","doi":"10.1088/1752-7163/ad7166","DOIUrl":"10.1088/1752-7163/ad7166","url":null,"abstract":"<p><p>Malignant pleural mesothelioma (MPM) is an aggressive cancer associated with asbestos exposure. MPM is often diagnosed late, at a point where limited treatment options are available, but early intervention could improve the chances of successful treatment for MPM patients. Biomarkers to detect MPM in at-risk individuals are needed to implement early diagnosis technologies. Volatile organic compounds (VOCs) have previously shown diagnostic potential as biomarkers when analysed in MPM patient breath. In this study, chorioallantoic membrane (CAM) xenografts of MPM cell lines were used as models of MPM tumour development for VOC biomarker discovery with the aim of generating targets for investigation in breath, biopsies or other complex matrices. VOC headspace analysis of biphasic or epithelioid MPM CAM xenografts was performed using solid-phase microextraction and gas chromatography-mass spectrometry. We successfully demonstrated the capture, analysis and separation of VOC signatures from CAM xenografts and controls. A panel of VOCs was identified that showed discrimination between MPM xenografts generated from biphasic and epithelioid cells and CAM controls. This is the first application of the CAM xenograft model for the discovery of VOC biomarkers associated with MPM histological subtypes. These findings support the potential utility of non-invasive VOC profiling from breath or headspace analysis of tissues for detection and monitoring of MPM.</p>","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11388873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-11DOI: 10.1088/1752-7163/ad7977
Waqar Ahmed,Max Wilkinson,Stephen J Fowler
Untargeted analysis of volatile organic compounds (VOCs) from exhaled breath and culture headspace can be influenced by several confounding factors that are not reflected in reference standards. In this study, we propose a method to generating pooled quality control (QC) samples for untargeted VOC studies using a split-recollection workflow for thermal desorption tubes. Sample tubes were desorbed with a 10% split from each sample and recollected onto a single tube, generating a pooled QC sample. This QC sample was then repeatedly desorbed and recollected with a sequentially lower split ratio allowing injection of up to ten QC samples. We found pooled QC samples to be representative of complex mixtures using principal component analysis (PCA) and may be useful in future longitudinal, multi-centre, and validation studies to assess data quality and adjust for batch effects.
{"title":"Generating pooled quality control samples of volatile organic compounds.","authors":"Waqar Ahmed,Max Wilkinson,Stephen J Fowler","doi":"10.1088/1752-7163/ad7977","DOIUrl":"https://doi.org/10.1088/1752-7163/ad7977","url":null,"abstract":"Untargeted analysis of volatile organic compounds (VOCs) from exhaled breath and culture headspace can be influenced by several confounding factors that are not reflected in reference standards. In this study, we propose a method to generating pooled quality control (QC) samples for untargeted VOC studies using a split-recollection workflow for thermal desorption tubes. Sample tubes were desorbed with a 10% split from each sample and recollected onto a single tube, generating a pooled QC sample. This QC sample was then repeatedly desorbed and recollected with a sequentially lower split ratio allowing injection of up to ten QC samples. We found pooled QC samples to be representative of complex mixtures using principal component analysis (PCA) and may be useful in future longitudinal, multi-centre, and validation studies to assess data quality and adjust for batch effects.","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":"9 1","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142181552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The prevalence of patients with bronchiectasis (BE) has been rising in recent years, which increases the substantial burden on the family and society. Exploring a convenient, effective, and low-cost screening tool for the diagnosis of BE is urgent. We expect to identify the accuracy of breath biomarkers(BBs) for the diagnosis of BE through breathomics testing and explore the association between BBs and clinical features of BE.
Method: Exhaled breath samples were collected and detected by high-pressure photon ionization time-of-flight mass spectrometry(HPPI-TOF MS) in a cross-sectional study. Exhaled breath samples were from 215 patients with BE and 295 control individuals. The potential BBs were selected via the machine learning method. The overall performance was assessed for the BBs-based BE detection model. The significant BBs between different subgroups such as the severity of BE, acute or stable stage, combined with hemoptysis or not, with or without Nontuberculous Mycobacterium (NTM), Pseudomonas aeruginosa (P.a) isolation or not, and the BBs related to the number of involved lung lobes and lung function were discovered and analyzed.
Results: The top 10 BBs based machine learning model achieved an area under the curve (AUC) of 0.940, sensitivity of 90.7%, specificity of 85%, and accuracy of 87.4% in BE diagnosis. Except for the top ten BBs, other BBs were found also related to the severity, acute/stable status, hemoptysis or not, NTM infection, P.a isolation, the number of involved lobes, and three lung functional paramters in BE patients.
Conclusions: BBs-based BE detection model showed good accuracy for diagnosis. BBs have a close relationship with the clinical features of BE. The breath test method may provide a new strategy for bronchiectasis screening and personalized management.
Clinical Trail Number: NCT05293314
.
近年来,支气管扩张症(BE)患者的发病率不断上升,这加重了家庭和社会的沉重负担。探索一种方便、有效、低成本的支气管扩张症筛查工具迫在眉睫。我们希望通过呼吸组学检测确定呼吸生物标志物(BBs)诊断 BE 的准确性,并探讨 BBs 与 BE 临床特征之间的关联:在一项横断面研究中收集呼出气体样本,并通过高压光子电离飞行时间质谱(HPPI-TOF MS)进行检测。呼气样本来自 215 名 BE 患者和 295 名对照组个体。通过机器学习方法筛选出潜在的BB。评估了基于BBs的BE检测模型的整体性能。发现并分析了不同亚组(如 BE 的严重程度、急性期或稳定期、是否合并咯血、有无非结核分枝杆菌(NTM)、铜绿假单胞菌(P.a)分离与否)之间的重要 BBs,以及与受累肺叶数量和肺功能相关的 BBs:基于前 10 个 BBs 的机器学习模型在 BE 诊断中的曲线下面积(AUC)为 0.940,灵敏度为 90.7%,特异度为 85%,准确率为 87.4%。除排名前十的 BBs 外,其他 BBs 也与 BE 患者的严重程度、急性/稳定状态、咯血与否、NTM 感染、P.a 分离、受累肺叶数和三个肺功能参数有关:基于 BBs 的 BE 检测模型显示出良好的诊断准确性。BBs与BE的临床特征有密切关系。呼气试验方法可为支气管扩张症筛查和个性化管理提供新策略:NCT05293314
.
{"title":"Discovery and Analysis of the Relationship between Organic Components in Exhaled Breath and Bronchiectasis.","authors":"Lichao Fan,Yan Chen,Yang Chen,Ling Wang,Shuo Liang,Kebin Cheng,Yue Pei,Yong Feng,Qingyun Li,Mengqi He,Ping Jiang,Haibin Chen,Jinfu Xu","doi":"10.1088/1752-7163/ad7978","DOIUrl":"https://doi.org/10.1088/1752-7163/ad7978","url":null,"abstract":"The prevalence of patients with bronchiectasis (BE) has been rising in recent years, which increases the substantial burden on the family and society. Exploring a convenient, effective, and low-cost screening tool for the diagnosis of BE is urgent. We expect to identify the accuracy of breath biomarkers(BBs) for the diagnosis of BE through breathomics testing and explore the association between BBs and clinical features of BE.
Method: Exhaled breath samples were collected and detected by high-pressure photon ionization time-of-flight mass spectrometry(HPPI-TOF MS) in a cross-sectional study. Exhaled breath samples were from 215 patients with BE and 295 control individuals. The potential BBs were selected via the machine learning method. The overall performance was assessed for the BBs-based BE detection model. The significant BBs between different subgroups such as the severity of BE, acute or stable stage, combined with hemoptysis or not, with or without Nontuberculous Mycobacterium (NTM), Pseudomonas aeruginosa (P.a) isolation or not, and the BBs related to the number of involved lung lobes and lung function were discovered and analyzed.
Results: The top 10 BBs based machine learning model achieved an area under the curve (AUC) of 0.940, sensitivity of 90.7%, specificity of 85%, and accuracy of 87.4% in BE diagnosis. Except for the top ten BBs, other BBs were found also related to the severity, acute/stable status, hemoptysis or not, NTM infection, P.a isolation, the number of involved lobes, and three lung functional paramters in BE patients.
Conclusions: BBs-based BE detection model showed good accuracy for diagnosis. BBs have a close relationship with the clinical features of BE. The breath test method may provide a new strategy for bronchiectasis screening and personalized management.

Clinical Trail Number: NCT05293314
.","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":"25 1","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142223804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-10DOI: 10.1088/1752-7163/ad748d
Hannah Van Wyk, Gwenyth O Lee, Robert J Schillinger, Christine A Edwards, Douglas J Morrison, Andrew F Brouwer
The13C-sucrose breath test (13C-SBT) has been proposed to estimate sucrase-isomaltase (SIM) activity and is a promising test for SIM deficiency, which can cause gastrointestinal symptoms, and for intestinal mucosal damage caused by gut dysfunction or chemotherapy. We previously showed how various summary measures of the13C-SBT breath curve reflect SIM inhibition. However, it is uncertain how the performance of these classifiers is affected by test duration. We leveraged13C-SBT data from a cross-over study in 16 adults who received 0, 100, and 750 mg of Reducose, an SIM inhibitor. We evaluated the performance of a pharmacokinetic-model-based classifier,ρ, and three empirical classifiers (cumulative percent dose recovered at 90 min (cPDR90), time to 50% dose recovered, and time to peak dose recovery rate), as a function of test duration using receiver operating characteristic (ROC) curves. We also assessed the sensitivity, specificity, and accuracy of consensus classifiers. Test durations of less than 2 h generally failed to accurately predict later breath curve dynamics. The cPDR90 classifier had the highest ROC area-under-the-curve and, by design, was robust to shorter test durations. For detecting mild SIM inhibition,ρhad a higher sensitivity. We recommend13C-SBT tests run for at least a 2 h duration. Although cPDR90 was the classifier with highest accuracy and robustness to test duration in this application, concerns remain about its sensitivity to misspecification of the CO2production rate. More research is needed to assess these classifiers in target populations.
{"title":"Performance of empirical and model-based classifiers for detecting sucrase-isomaltase inhibition using the<sup>13</sup>C-sucrose breath test.","authors":"Hannah Van Wyk, Gwenyth O Lee, Robert J Schillinger, Christine A Edwards, Douglas J Morrison, Andrew F Brouwer","doi":"10.1088/1752-7163/ad748d","DOIUrl":"10.1088/1752-7163/ad748d","url":null,"abstract":"<p><p>The<sup>13</sup>C-sucrose breath test (<sup>13</sup>C-SBT) has been proposed to estimate sucrase-isomaltase (SIM) activity and is a promising test for SIM deficiency, which can cause gastrointestinal symptoms, and for intestinal mucosal damage caused by gut dysfunction or chemotherapy. We previously showed how various summary measures of the<sup>13</sup>C-SBT breath curve reflect SIM inhibition. However, it is uncertain how the performance of these classifiers is affected by test duration. We leveraged<sup>13</sup>C-SBT data from a cross-over study in 16 adults who received 0, 100, and 750 mg of Reducose, an SIM inhibitor. We evaluated the performance of a pharmacokinetic-model-based classifier,ρ, and three empirical classifiers (cumulative percent dose recovered at 90 min (cPDR90), time to 50% dose recovered, and time to peak dose recovery rate), as a function of test duration using receiver operating characteristic (ROC) curves. We also assessed the sensitivity, specificity, and accuracy of consensus classifiers. Test durations of less than 2 h generally failed to accurately predict later breath curve dynamics. The cPDR90 classifier had the highest ROC area-under-the-curve and, by design, was robust to shorter test durations. For detecting mild SIM inhibition,ρhad a higher sensitivity. We recommend<sup>13</sup>C-SBT tests run for at least a 2 h duration. Although cPDR90 was the classifier with highest accuracy and robustness to test duration in this application, concerns remain about its sensitivity to misspecification of the CO<sub>2</sub>production rate. More research is needed to assess these classifiers in target populations.</p>","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11385691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142093212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-13DOI: 10.1088/1752-7163/ad6a31
Mateusz Fido, Simone Hersberger, Andreas T Güntner, Renato Zenobi, Stamatios Giannoukos
Polymeric bags are a widely applied, simple, and cost-effective method for the storage and offline analysis of gaseous samples. Various materials have been used as sampling bags, all known to contain impurities and differing in their cost, durability, and storage capabilities. Herein, we present a comparative study of several well-known bag materials, Tedlar (PVF), Kynar (PVDF), Teflon (PTFE), and Nalophan (PET), as well as a new material, ethylene vinyl copolymer (EVOH), commonly used for storing food. We investigated the influences of storage conditions, humidity, bag cleaning, and light exposure on volatile organic compound concentration (acetone, acetic acid, isoprene, benzene, limonene, among others) in samples of exhaled human breath stored in bags for up to 48 h. Specifically, we show high losses of short-chain fatty acids (SCFAs) in bags of all materials (for most SCFAs, less than 50% after 8 h of storage). We found that samples in Tedlar, Nalophan, and EVOH bags undergo changes in composition when exposed to UV radiation over a period of 48 h. We report high initial impurity levels in all the bags and their doubling after a period of 48 h. We compare secondary electrospray ionization and proton transfer reaction mass spectrometry in the context of offline analysis after storage in sampling bags. We provide an analytical perspective on the temporal evolution of bag contents by presenting the intensity changes of all significantm/zfeatures. We also present a simple, automated, and cost-effective offline sample introduction system, which enables controlled delivery of collected gaseous samples from polymeric bags into the mass spectrometer. Overall, our findings suggest that sampling bags exhibit high levels of impurities, are sensitive to several environmental factors (e.g. light exposure), and provide low recoveries for some classes of compounds, e.g. SCFAs.
{"title":"Systematic study of polymer gas sampling bags for offline analysis of exhaled breath.","authors":"Mateusz Fido, Simone Hersberger, Andreas T Güntner, Renato Zenobi, Stamatios Giannoukos","doi":"10.1088/1752-7163/ad6a31","DOIUrl":"10.1088/1752-7163/ad6a31","url":null,"abstract":"<p><p>Polymeric bags are a widely applied, simple, and cost-effective method for the storage and offline analysis of gaseous samples. Various materials have been used as sampling bags, all known to contain impurities and differing in their cost, durability, and storage capabilities. Herein, we present a comparative study of several well-known bag materials, Tedlar (PVF), Kynar (PVDF), Teflon (PTFE), and Nalophan (PET), as well as a new material, ethylene vinyl copolymer (EVOH), commonly used for storing food. We investigated the influences of storage conditions, humidity, bag cleaning, and light exposure on volatile organic compound concentration (acetone, acetic acid, isoprene, benzene, limonene, among others) in samples of exhaled human breath stored in bags for up to 48 h. Specifically, we show high losses of short-chain fatty acids (SCFAs) in bags of all materials (for most SCFAs, less than 50% after 8 h of storage). We found that samples in Tedlar, Nalophan, and EVOH bags undergo changes in composition when exposed to UV radiation over a period of 48 h. We report high initial impurity levels in all the bags and their doubling after a period of 48 h. We compare secondary electrospray ionization and proton transfer reaction mass spectrometry in the context of offline analysis after storage in sampling bags. We provide an analytical perspective on the temporal evolution of bag contents by presenting the intensity changes of all significant<i>m</i>/<i>z</i>features. We also present a simple, automated, and cost-effective offline sample introduction system, which enables controlled delivery of collected gaseous samples from polymeric bags into the mass spectrometer. Overall, our findings suggest that sampling bags exhibit high levels of impurities, are sensitive to several environmental factors (e.g. light exposure), and provide low recoveries for some classes of compounds, e.g. SCFAs.</p>","PeriodicalId":15306,"journal":{"name":"Journal of breath research","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141874893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}